Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statement of Changes In Equity

v3.19.1
Unaudited Condensed Consolidated Statement of Changes In Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Non-Controlling Interests In Subsidiaries [Member]
Balance at Dec. 31, 2017 $ 523,166,000 $ 177,000 $ 303,996,000   $ 216,511,000 $ (12,493,000) $ 14,975,000
Balance (in shares) at Dec. 31, 2017   17,675,356          
Impact of adoption of new accounting standard at Dec. 31, 2017 (12,069,000)       (12,069,000)    
Balance at Dec. 31, 2017 511,097,000 $ 177,000 303,996,000   204,442,000 (12,493,000) 14,975,000
Issuance of Common Stock 1,793,000 $ 1,000 1,792,000        
Issuance of Common Stock (in shares)   138,399          
Amortization of employee share awards 476,000   476,000        
Amortization of employee share awards (Shares)   (27,186)          
Acquisition of consolidated joint venture (12,037,000)           (12,037,000)
Issuance of noncontrolling interests 31,385,000   375,000       31,010,000
Net Loss (31,688,000)       (28,833,000)   (2,855,000)
Other comprehensive loss 2,146,000         2,069,000 77,000
Balance at Mar. 31, 2018 503,172,000 $ 178,000 306,639,000   175,609,000 (10,424,000) 31,170,000
Balance (in shares) at Mar. 31, 2018   17,786,569          
Balance at Dec. 31, 2018 $ 554,935,000 $ 204,000 415,372,000 $ (91,000) 126,834,000 (16,788,000) 29,404,000
Balance (in shares) at Dec. 31, 2018 20,443,215 20,439,208   4,007      
Impact of adoption of new accounting standard at Dec. 31, 2018 $ 10,416,000       10,416,000    
Balance at Dec. 31, 2018 565,351,000 $ 204,000 415,372,000 $ (91,000) 137,250,000 (16,788,000) 29,404,000
Issuance of Common Stock 6,596,000 $ 7,000 6,589,000        
Issuance of Common Stock (in shares)   653,872          
Amortization of employee share awards 776,000   776,000        
Exercise of options $ 108,000   108,000        
Exercise of options (in shares) 8,750 8,750          
Restricted stock vesting $ (281,833)     $ (282,000)      
Restricted stock vesting (in shares) (21,551) (21,551)   21,551      
Cancellation of employee share awards $ (15,000)   (15,000)        
Cancellation of employee share awards (in shares)   (1,000)          
Acquisition of consolidated joint venture (2,114,000)           (2,114,000)
Net Loss (28,273,000)       (25,549,000)   (2,724,000)
Other comprehensive loss (24,000)         (24,000)  
Balance at Mar. 31, 2019 $ 542,123,000 $ 211,000 $ 422,830,000 $ (373,000) $ 111,701,000 $ (16,812,000) $ 24,566,000
Balance (in shares) at Mar. 31, 2019 21,104,837 21,079,279   25,558